DK219083A - Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt - Google Patents

Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt Download PDF

Info

Publication number
DK219083A
DK219083A DK219083A DK219083A DK219083A DK 219083 A DK219083 A DK 219083A DK 219083 A DK219083 A DK 219083A DK 219083 A DK219083 A DK 219083A DK 219083 A DK219083 A DK 219083A
Authority
DK
Denmark
Prior art keywords
lactaining
sesquiter
pen
extract
procedure
Prior art date
Application number
DK219083A
Other languages
English (en)
Other versions
DK219083D0 (da
Inventor
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Original Assignee
Edward Stewart Johnson
Peter John Hylands
Deborah Margaret Hylands
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26282867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK219083(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edward Stewart Johnson, Peter John Hylands, Deborah Margaret Hylands filed Critical Edward Stewart Johnson
Publication of DK219083D0 publication Critical patent/DK219083D0/da
Publication of DK219083A publication Critical patent/DK219083A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK219083A 1982-05-19 1983-05-17 Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt DK219083A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8214572 1982-05-19
GB8227062 1982-09-22

Publications (2)

Publication Number Publication Date
DK219083D0 DK219083D0 (da) 1983-05-17
DK219083A true DK219083A (da) 1983-11-20

Family

ID=26282867

Family Applications (1)

Application Number Title Priority Date Filing Date
DK219083A DK219083A (da) 1982-05-19 1983-05-17 Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt

Country Status (13)

Country Link
US (1) US4758433A (da)
EP (1) EP0098041B1 (da)
KR (1) KR840004511A (da)
AR (1) AR230008A1 (da)
AU (1) AU564371B2 (da)
CA (1) CA1270843A (da)
DE (1) DE3380306D1 (da)
DK (1) DK219083A (da)
FI (1) FI831740L (da)
GB (1) GB2124486B (da)
IE (1) IE55766B1 (da)
NO (1) NO831762L (da)
NZ (1) NZ204256A (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635522A1 (de) * 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
WO1989005651A1 (en) * 1987-12-23 1989-06-29 Psoricur Ltd. Therapeutical compositions against psoriasis
GB9100581D0 (en) * 1991-01-11 1991-02-27 Rhodes Technology Method for the extraction of sesquiterpene lactones
DE4202657C2 (de) * 1992-01-31 1995-10-12 Schaper & Bruemmer Gmbh Pharmazeutisch wirksame Zusammensetzung aus Tanacetum parthenium sowie Verfahren zu deren Extraktion und mit der pharmazeutisch wirksamen Zusammensetzung hergestelltes Arzneimittel
US5278172A (en) * 1992-07-24 1994-01-11 Hennessey Richard K Method and composition for treating tendon or joint inflammation using a vasodilator
US5576329A (en) * 1992-07-24 1996-11-19 Hennessey; Richard K. Method for treating tendon or joint inflammation with papaverine HCL
CN1056142C (zh) * 1993-01-04 2000-09-06 昆明医学院第一附属医院 水朝阳内酯的制备方法
CA2141126A1 (en) * 1995-01-26 1996-07-27 Natalie J. Lazarowych Combinational drug for treating migraine and other illnesses
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
DK1007067T3 (da) * 1996-10-21 2002-05-06 Eurovita As Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ...
US5905089A (en) * 1997-04-14 1999-05-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of sesquiterpene lactones for treatment of severe inflammatory disorders
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
WO1999033463A1 (en) * 1997-12-23 1999-07-08 Moser, René SESQUITERPENE LACTONES SPECIFICALLY INHIBIT ACTIVATION OF NF-λB BY PREVENTING THE DEGRADATION OF IλB-α AND IλB-$g(b)
US6225339B1 (en) * 1998-01-29 2001-05-01 Pfizer Inc. Terpenoid lactone compounds and their production process
US6068999A (en) 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
US6221899B1 (en) 1999-01-15 2001-04-24 Pfizer Inc. Terpenoid lactone compounds and their production process
KR100755798B1 (ko) * 1999-06-03 2007-09-07 죤슨 앤 죤슨 컨슈머 프랑스 에스에이에스 화란국화(타나세텀 파르테니움) 추출물을 포함하는 국소 조성물과, 이 조성물을 사용해서 염증 질환을 치료 및 예방하는 방법
US20030003170A1 (en) * 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
IT1312342B1 (it) 1999-06-03 2002-04-15 Indena Spa Estratto di tanacetum parthenium sostanzialmente privo di gammalattoni-alfa-insaturi.
US6642243B1 (en) 1999-07-22 2003-11-04 Ashkan Imanzahrai Migraine medicine and method for treating same
DE10015617A1 (de) * 2000-03-29 2001-10-04 Peter Laetzsch Migränemittel
IN188857B (da) * 2000-07-14 2002-11-16 Govind Kane Dr Shantaram
US20030077343A1 (en) * 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
MXPA03008391A (es) * 2001-03-16 2004-11-12 Johnson & Johnson Composicion que contiene extracto de matricaria y uso de la misma.
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US7678904B2 (en) 2003-07-11 2010-03-16 University Of Kentucky Use of parthenolide derivatives as antileukemic and cytotoxic agents
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
US20060222722A1 (en) * 2005-03-30 2006-10-05 Roberts Stephen C Sublingual methods of treatment to alleviate or prevent arthritis
EP2170324A4 (en) * 2007-06-21 2010-11-03 Puramed Bioscience Inc COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MIGRAINE HEADACHE AND ASSOCIATED SYMPTOMS
US10500182B2 (en) * 2018-01-10 2019-12-10 Robert Firger Compositions of ketogenic sources, micronutrients and phytochemicals for prophylaxis and mitigation of migraine headache
CN109761994B (zh) * 2019-02-28 2021-06-29 中国科学院新疆理化技术研究所 降碳类愈创木烷型倍半萜内酯类化合物及其制备方法

Also Published As

Publication number Publication date
EP0098041A3 (en) 1984-12-12
NO831762L (no) 1983-11-21
IE831164L (en) 1983-11-19
KR840004511A (ko) 1984-10-22
AR230008A1 (es) 1984-02-29
IE55766B1 (en) 1991-01-16
CA1270843A (en) 1990-06-26
GB2124486B (en) 1986-07-16
AU1464683A (en) 1983-11-24
FI831740A0 (fi) 1983-05-18
FI831740L (fi) 1983-11-20
AU564371B2 (en) 1987-08-13
DK219083D0 (da) 1983-05-17
EP0098041B1 (en) 1989-08-02
US4758433A (en) 1988-07-19
EP0098041A2 (en) 1984-01-11
GB2124486A (en) 1984-02-22
DE3380306D1 (en) 1989-09-07
NZ204256A (en) 1988-02-29
GB8313530D0 (en) 1983-06-22

Similar Documents

Publication Publication Date Title
DK219083A (da) Fremgangsmaade til fremstilling af en sesquiterpenlaktonholdig ekstrakt
DK1183A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK158282C (da) Fremgangsmaade til fremstilling af et fast fibrinogenpraeparat
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK343581A (da) Fremgangsmaade til fremstilling af et triamterenpraeparat
DK522081A (da) Fremgangsmaade til fremstilling af xanthater
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK299483D0 (da) Fremgangsmade til fremstilling af n-phosphonomethylglycin
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK283083A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK226379A (da) Fremgangsmaade til fremstilling af harpikser
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK152043C (da) Fremgangsmaade til fremstilling af et ranitidin
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK394783A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK62283A (da) Fremgangsmaade til fremstilling af peptidergotalkaloider
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
DK9383A (da) Fremgangsmaade til fremstilling af phosphinoxider
DK10883A (da) Fremgangsmaade til fremstilling af substituerede chloracetanilider
DK66483D0 (da) Fremgangsmade til fremstilling af ergotalkaloider
DK96383A (da) Fremgangsmaade til fremstilling af 3-azetidinylaetyl-1-fenyl-2-imidazolidinonderivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment